Fibromyalgia (FM) is a chronic, widespread pain syndrome affecting 2-6.6% of the population and significantly impairing quality of life. In addition to pain, individuals with FM commonly experience fatigue, sleep disturbances, cognitive and psychological problems, leading to functional limitations and social difficulties. Central sensitization is considered a key mechanism, although the exact pathophysiology remains unclear, highlighting the need for multidimensional assessment. FM affects not only physical function but also psychological status, autonomic nervous system regulation, sleep quality, self-esteem, eating behaviors, and gastrointestinal function. Depression, anxiety, autonomic dysfunction, sleep disorders, altered eating behaviors, and gastrointestinal symptoms are highly prevalent and closely associated with pain severity, fatigue, and reduced quality of life. Given its complex biopsychosocial nature, FM requires a holistic evaluation and management approach. Accordingly, this study aims to compare symptoms, psychological status, autonomic function, sleep, eating behaviors, and gastrointestinal parameters between women with fibromyalgia and healthy women.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Assessment of Pain Intensity
Timeframe: Baseline
Assessment of Fatigue
Timeframe: Baseline
Perceived Stress Scale-10 (PSS-10)
Timeframe: Baseline
Hospital Anxiety and Depression Scale (HADS)
Timeframe: Baseline
Rosenberg Self-Esteem Scale (RSES)
Timeframe: Baseline
COMPASS-31 Autonomic Symptom Questionnaire
Timeframe: Baseline
Pittsburgh Sleep Quality Index (PSQI)
Timeframe: Baseline
Three-Factor Eating Questionnaire (TFEQ-18)
Timeframe: Baseline
Gastrointestinal Symptom Rating Scale (GSRS)
Timeframe: Baseline